View Cart (0 items)

Items Tagged with 'Mergers & acquisitions'

ARTICLES

Allergan enters acquisition deal with Actavis

Botox maker Allergan, Inc. will be acquired by Actavis plc for $66 billion after fending off a hostile takeover bid by activist investor William Ackman and Valeant Pharmaceuticals International Inc.
Read More

Western Gas to acquire Nuevo Midstream for $1.5 billion

Nuevo Midstream, LLC, a company that gathers, treats, processes, transports and markets natural gas, is to be acquired by Western Gas Partners, LP.
Read More

Novartis to sell influenza vaccines business for $275 million

Healthcare company Novartis has entered into an agreement to sell its influenza vaccines unit for $275 million.
Read More

Auxilium Pharmaceuticals agrees to acquisition deal with Endo

Specialty biopharmaceutical company Auxilium Pharmaceuticals, Inc. is to be acquired by Endo International plc for $2.6 billion, including the repayment and assumption of debt.
Read More

Aqua America makes water, wastewater acquisitions in Texas

Aqua America, Inc. has expanded its footprint by acquiring the water and wastewater system assets of Texas H2O, a family-owned utility based in Mansfield, Texas.
Read More

Russian construction materials firm acquires Italiana Membrane

Russian construction materials supplier TechnoNicol Corp. has expanded its footprint in Western Europe with the acquisition of Italiana Membrane, an Italian manufacturer of building materials.


Read More

WhiteWave Foods to acquire So Delicious Dairy Free

The WhiteWave Foods Company, maker of Silk brand plant-based foods and beverages, has agreed to acquire So Delicious Dairy Free from its existing shareholders for $195 million.
Read More

OPW to acquire Australia's Liquip

Fluid-handling solutions specialist OPW said on Monday that it has agreed to acquire all outstanding shares of Australian company Liquip International.
Read More

VanDeMark Chemical acquires European phosgene producer

VanDeMark Chemical Inc., a U.S. manufacturer of phosgene and phosgene derivatives, has expanded its business with the acquisition of a European manufacturer of phosgene products.
Read More

US pharma major Abbott to pay $2.9 billion for Chile's CFR

U.S. pharmaceuticals and healthcare products major Abbott Laboratories has agreed to acquire Chile-based pharmaceutical firm CFR Pharmaceuticals SA in a deal worth $2.9 billion.
Read More